[1]Qaseem A,Fihn SD,Williams S,et al.Diagnosis of stable ischemic heart disease:summary of a clinical practice guideline from the American college of physicians/American college of cardiology foundation/American heart association/American association for thoracic surgery/preventive cardiovascular nurses association/society of thoracic surgeons[J].Ann Intl Med,2012,157(10):729-734. [2]Roffi M,Patrono C,Collet JP,et al.2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st- segment elevation[J].Revista Espanola de ardiologia (Engled),2015,68(12):1125. [3]高光仁,冯连荣,张新如等.STEMI与NSTE-ACS的临床特征及冠状动脉病变特点比较.中国医药导刊杂志[J].2016,18(11):1105-1106. [4]Jousilahti P,Laatikainen T,Pelttonen M,et al.Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 yesrs:popolation based observational study[J].BMJ,2016,352:i721. [5] 韩永华,刘善伟,韩芸等.焦虑对急性冠脉综合征患者PCI术后生存状况的影响.中国医药导刊杂志[J].2017,19(1):15-16. [6] Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch,2004,447(5):653. [7]Yoshida K,Maeda K,Sugiyama Y.Hepatic and intestinal drug transporters:prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms.Annu Rev Pharmacol Toxicol,2013,53:581-612. [8] Niemi M. Role of OATP transporters in the disposition of drugs[J]. Pharmacogenomics , 2007 , 8 (7) : 787-802. [9] Cui Y, Konig J , Leier I , et al . Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 [J] . J Biol Chem , 2001 , 276 (13) : 9626-9630. [10] Tamai I , Nezu J , Uchino H , et al . Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family [J] . Biochem Biophys Res Commun , 2000 , 273 (1) : 251-260. [11] Abe T , Kakyo M , Tokui T , et al . Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1 [J] . J Biol Chem , 1999 , 274 ( 24 ) : 17159-17163. [12] Pasanen MK, Miettinen TA, Gylling H, et al. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate[J ]. Pharmacogenet Genomics, 2008, 18(10):921-926. [13]Niemi M, Pasanen MK, Neuvonen PJ.Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake [J]. Pharmacol Rev, 2011, 63: 157?181. [14] Campbell SD, de Morais SM, Xu JJ. Inhibition of human organic anion transporting polypeptide OATP1B1 as a mechanism of drug-induced hyperbilirubinemia [J]. Chem Biol Interact, 2004, 150: 179?187. [15]王苗苗. 血清总胆红素水平与心绞痛患者经皮冠状动脉介入治疗后预后的关系研究. 实用心脑肺血管病杂志[J]. 2016,12(24):23-28. [16]YOSHINO S,HAMASAKI S,ISHIDA S,et al.Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol[J].Heart Vessels,2013,28(2):157-165. [17]王树源,黄家卓.血清总胆红素水平与ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术前梗死相关动脉血流及院内主要心脏不良事件的相关性研究[J].实用心脑肺血管病杂志,2016,24(3):11-14. [18]陈国栋,肖瑾,刘宾荣等.急性缺血性卒中患者血清胆红素水平与病情严重程度和短期转归的关系[J].国际脑血管病杂志,2016,24 (2):157-162. [19]陈刚,廖志良,刘笃秋等.亚临床甲状腺功能减退症与冠状动脉粥样硬化性心脏病的相关性[J].海南医学杂志,2017,2(28):372-373. [20]华丽,曹国君,邢志芳等.血尿酸、三酰甘油及高密度脂蛋白对冠心病及其严重程度的联合风险评估[J].国际检验医学杂志,2016,12(37):3410-3413.
|